These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28927095)

  • 21. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
    Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
    Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated HBXIP expression is associated with aggressive phenotype and poor prognosis in esophageal squamous cell carcinoma.
    Xia H; Ma L; Li J; Bai H; Wang D
    Am J Cancer Res; 2017; 7(11):2190-2198. PubMed ID: 29218243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
    Yang H; Wei YN; Zhou J; Hao TT; Liu XL
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression, Function, and Prognostic Value of MAGE-D4 Protein in Esophageal Squamous Cell Carcinoma.
    Uno Y; Kanda M; Sato Y; Shimizu D; Umeda S; Hattori N; Hayashi M; Tanaka C; Kobayashi D; Yamada S; Nakayama G; Motoyama S; Koike M; Kodera Y
    Anticancer Res; 2019 Nov; 39(11):6015-6023. PubMed ID: 31704827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.
    Wang H; Deng F; Liu Q; Ma Y
    Pathol Res Pract; 2017 Jul; 213(7):842-847. PubMed ID: 28554754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
    Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
    Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of long non-coding RNA ZEB1-AS1 in esophageal squamous cell carcinoma and its correlation with tumor progression and patient survival.
    Wang YL; Bai Y; Yao WJ; Guo L; Wang ZM
    Int J Clin Exp Pathol; 2015; 8(9):11871-6. PubMed ID: 26617942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrin α5 promotes tumor progression and is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma.
    Xie JJ; Guo JC; Wu ZY; Xu XE; Wu JY; Chen B; Ran LQ; Liao LD; Li EM; Xu LY
    Hum Pathol; 2016 Feb; 48():69-75. PubMed ID: 26772401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The decreased expression of miR-625 predicts poor prognosis of esophageal squamous cell carcinoma.
    Li C; Li DC; Che SS; Ma K; Wang YJ; Xia LH; Dai XM; Zhang GT; Shen Y; Jiao WJ; Tian KH
    Int J Clin Exp Med; 2015; 8(6):9560-4. PubMed ID: 26309624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
    Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
    Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
    Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
    Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deregulation of decorin and FHL1 are associated with esophageal squamous cell carcinoma progression and poor prognosis.
    Ji C; Liu H; Xiang M; Liu J; Yue F; Wang W; Chu X
    Int J Clin Exp Med; 2015; 8(11):20965-70. PubMed ID: 26885026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppressor PAQR3 associated with the clinical significance and prognosis in esophageal squamous cell carcinoma.
    Bai G; Yang M; Zheng C; Zhang L; Eli M
    Oncol Lett; 2018 Apr; 15(4):5703-5711. PubMed ID: 29552204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
    Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.
    Jiang D; Song Q; Wang H; Huang J; Wang H; Hou J; Li X; Xu Y; Sujie A; Zeng H; Tan L; Hou Y
    Oncotarget; 2017 Jan; 8(5):8315-8329. PubMed ID: 28039448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and prognostic value of FOXP1 in esophageal squamous cell carcinoma.
    Wei Q; Li X; Zhu Z; Yu W; Qin G; Chen H; Gu Y; Zhao K; Fu X; Sun M
    Pathol Res Pract; 2019 Dec; 215(12):152645. PubMed ID: 31704154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
    Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
    BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.